Indicator disease-guided testing for HIV--the next step for Europe? (Q37192570)

18 August 2017

1 reference

title

Indicator disease-guided testing for HIV--the next step for Europe? (English)

1 reference

Antonella d'Arminio Monforte

18 August 2017

0 references

series ordinal

3

object named as

A d'Arminio Monforte

1 reference

18 August 2017

4

J D Lundgren

1 reference

18 August 2017

B Gazzard

1

1 reference

PubMed ID

18557871

18 August 2017

N Clumeck

series ordinal

2

1 reference

PubMed ID

18557871

18 August 2017

language of work or name

1 reference

1 July 2008

1 reference

18 August 2017

1 reference

18 August 2017

9 Suppl 2

1 reference

18 August 2017

34-40

1 reference

Correlates of late HIV diagnosis: implications for testing policy

18 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2008.00592.X

HIV incidence and HIV testing behavior in men who have sex with men: using three incidence sources, The Netherlands, 1984-2005.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2008.00592.X

Cost-effectiveness implications of the timing of antiretroviral therapy in HIV-infected adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2008.00592.X

Routine human immunodeficiency virus testing: an economic evaluation of current guidelines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2008.00592.X

Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2008.00592.X

Expanded screening for HIV in the United States--an analysis of cost-effectiveness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2008.00592.X

Cost-effectiveness of screening for HIV in the era of highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2008.00592.X

The evaluation of subcutaneous proleukin (interleukin-2) in a randomized international trial: rationale, design, and methods of ESPRIT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2008.00592.X

Tuberculosis and HIV seroprevalence in Lambeth, Southwark and Lewisham, an area of South London

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2008.00592.X

The European Confederation of Medical Mycology (ECMM) survey of candidaemia in Italy: antifungal susceptibility patterns of 261 non-albicans Candida isolates from blood.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2008.00592.X

Determinants of disease presentation and outcome during cryptococcosis: the CryptoA/D study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2008.00592.X

National multicenter study of HIV testing and HIV seropositivity in patients with chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2008.00592.X

Extrahepatic manifestations associated with hepatitis C virus infection. A prospective multicenter study of 321 patients. The GERMIVIC. Groupe d'Etude et de Recherche en Medecine Interne et Maladies Infectieuses sur le Virus de l'Hepatite C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2008.00592.X

Progression to end-stage liver disease in patients with inherited bleeding disorders and hepatitis C: an international, multicenter cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2008.00592.X

Hepatitis C in France: a national survey in the Departments of Internal Medicine and Infectious Diseases. The GERMIVIC (Joint Study Group on Hepatitis C virus of the French National Society of Internal Medicine and the French Society of Infectious D

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2008.00592.X

Update on lymphogranuloma venereum in the United Kingdom

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2008.00592.X

Mother-to-child transmission of HIV infection in Romania: results from an education and prevention programme

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2008.00592.X

Antenatal HIV testing: assessment of a routine voluntary approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2008.00592.X

The validity of medical history, classic symptoms, and chest radiographs in predicting pulmonary tuberculosis: derivation of a pulmonary tuberculosis prediction model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2008.00592.X

Cost and incidence of social comorbidities in low-risk patients with community-acquired pneumonia admitted to a public hospital.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2008.00592.X

Hospitalized community-acquired pneumonia due to Streptococcus pneumoniae: Has resistance to antibiotics decreased?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2008.00592.X

Follow-up of epidemiological data of cryptococcosis in Austria, Germany and Switzerland with special focus on the characterization of clinical isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2008.00592.X

Derivation and validation of guidelines for stool cultures for enteropathogenic bacteria other than Clostridium difficile in hospitalized adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2008.00592.X

Infectious mononucleosis-like syndromes in febrile travelers returning from the tropics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2008.00592.X

Prevalence of oral lesions among HIV-infected intravenous drug abusers and other risk groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2008.00592.X

Risk of human immunodeficiency virus type 1 transmission through breastfeeding

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2008.00592.X

Antenatal HIV screening in Europe: a review of policies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2008.00592.X

Uptake and acceptability of antenatal HIV testing: randomised controlled trial of different methods of offering the test

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2008.00592.X

Uptake of antenatal HIV testing in the United Kingdom: 2000-2003.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2008.00592.X

Gastrointestinal leishmaniasis in human immunodeficiency virus-infected patients: report of five cases and review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2008.00592.X

Cytomegalovirus infection in gastrointestinal tracts of patients infected with HIV-1 or AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2008.00592.X

High rates of forward transmission events after acute/early HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2008.00592.X

Herpes Zoster in African Patients: An Early Manifestation of HIV Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2008.00592.X

10.1111/J.1468-1293.2008.00592.X

21 January 2018

Identifiers

DOI

1 reference

18 August 2017

1 reference

PubMed ID

18557871